IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, Universidade do Minho, Campus de Gualtar, 4710-057, Portugal, Portugal.
Appl Microbiol Biotechnol. 2013 Aug;97(15):6779-91. doi: 10.1007/s00253-012-4559-1. Epub 2012 Nov 20.
The Escherichia coli host system is an advantageous choice for simple and inexpensive recombinant protein production but it still presents bottlenecks at expressing soluble proteins from other organisms. Several efforts have been taken to overcome E. coli limitations, including the use of fusion partners that improve protein expression and solubility. New fusion technologies are emerging to complement the traditional solutions. This work evaluates two novel fusion partners, the Fh8 tag (8 kDa) and the H tag (1 kDa), as solubility enhancing tags in E. coli and their comparison to commonly used fusion partners. A broad range comparison was conducted in a small-scale screening and subsequently scaled-up. Six difficult-to-express target proteins (RVS167, SPO14, YPK1, YPK2, Frutalin and CP12) were fused to eight fusion tags (His, Trx, GST, MBP, NusA, SUMO, H and Fh8). The resulting protein expression and solubility levels were evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis before and after protein purification and after tag removal. The Fh8 partner improved protein expression and solubility as the well-known Trx, NusA or MBP fusion partners. The H partner did not function as a solubility tag. Cleaved proteins from Fh8 fusions were soluble and obtained in similar or higher amounts than proteins from the cleavage of other partners as Trx, NusA or MBP. The Fh8 fusion tag therefore acts as an effective solubility enhancer, and its low molecular weight potentially gives it an advantage over larger solubility tags by offering a more reliable assessment of the target protein solubility when expressed as a fusion protein.
大肠杆菌宿主系统是一种用于简单、廉价的重组蛋白生产的有利选择,但在表达来自其他生物体的可溶性蛋白时仍然存在瓶颈。已经采取了几种措施来克服大肠杆菌的局限性,包括使用改善蛋白表达和可溶性的融合伴侣。新的融合技术正在涌现,以补充传统的解决方案。本工作评估了两种新型融合伴侣,即 Fh8 标签(8 kDa)和 H 标签(1 kDa),作为大肠杆菌中提高可溶性的标签,并将其与常用的融合伴侣进行比较。在小规模筛选中进行了广泛的比较,然后进行了放大。将六种难以表达的靶蛋白(RVS167、SPO14、YPK1、YPK2、Frutalin 和 CP12)融合到八种融合标签(His、Trx、GST、MBP、NusA、SUMO、H 和 Fh8)中。通过在蛋白质纯化前后以及标签去除后进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳评估所得蛋白的表达和可溶性水平。Fh8 伴侣提高了蛋白的表达和可溶性,与著名的 Trx、NusA 或 MBP 融合伴侣一样。H 伴侣不能作为可溶性标签。从 Fh8 融合中切割的蛋白质是可溶性的,并且在数量上与从 Trx、NusA 或 MBP 等其他伴侣的切割中获得的蛋白质相似或更高。因此,Fh8 融合标签是一种有效的可溶性增强剂,其低分子量使其在作为融合蛋白表达时,对目标蛋白可溶性的评估更可靠,从而具有比更大的可溶性标签更大的优势。